Novo Offers New Emergency Glucagon Injection
In July 2005, Novo Nordisk announced the availability of its GlucaGen HypoKit (injectable glucagon of rDNA origin) for the treatment of severe hypoglycemic reactions that may occur in people with insulin-dependent diabetes.
“The GlucaGen HypoKit is fully portable and can be used wherever it is needed, in any setting,” says a spokesperson for Novo Nordisk. The GlucaGen HypoKit is an emergency kit consisting of a syringe prefilled with sterile water for mixing and a vial of GlucaGen powder. The hard-shell, bright orange case provides product protection, requires no refrigeration, and is easily identifiable in an emergency.
“GlucaGen HypoKit has comprehensive picture instructions for the administrator during an emergency situation and holds no danger of overdose,” says Novo Nordisk. “Family members or caregivers should practice and become familiar with the technique of preparing glucagon before an emergency arises. Additionally, GlucaGen HypoKit is safe for use in children.”
Peter Aurup, MD, vice president of clinical development, medical and regulatory affairs at Novo Nordisk, says, “Making GlucaGen available to people living with diabetes in a non-hospital setting addresses a huge unmet medical need because a vast majority of patients on insulin therapy do not currently own a glucagon emergency kit.”
For more information about the GlucaGen HypoKit, contact Novo Nordisk at (800) 727-6500 or visit www.novonordisk-us.com.
Source: Novo NordiskClick Here To View Or Post Comments